Novo Nordisk A/S ADR buy Haans
Start price
16.02.16
/
50%
€44.57
Target price
11.04.16
€58.00
Performance (%)
12.12%
End price
11.04.16
€49.11
Summary
This prediction ended on 11.04.16 with a price of €49.11. The prediction had a final performance of 12.12%. Haans has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 9.245% | 9.245% | -38.955% | -58.381% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by Haans for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Trendaktie...
Diabetis ist noch wohl noch lange im Trend. Auch die Abott sollte man sich näher anschauen.
(Vom Mitglied beendet)
Stopped prediction by Haans for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€41.58
24.08.16
24.08.16
€50.00
24.02.17
24.02.17
-19.18%
24.02.17
24.02.17


